ASTH vs. TER

Last updated Apr 1, 2026

Compare and contrast key facts about Astrana Health Inc (ASTH) and Teradyne, Inc. (TER).

Performance

ASTH vs. TER - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Astrana Health Inc (ASTH) and Teradyne, Inc. (TER). The values are adjusted to include any dividend payments, if applicable.

ASTH vs. TER - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ASTH Astrana Health Inc	-1.17%	-21.31%	-17.68%	29.44%	-59.73%	302.19%	-0.76%	-7.25%	-17.29%	220.00%
TER Teradyne, Inc.	53.23%	54.39%	16.51%	24.78%	-46.35%	36.81%	76.73%	118.93%	-24.37%	66.16%

Fundamentals

Market Cap ASTH : $1.21B TER : $46.74B
EPS ASTH : $0.45 TER : $3.48
PE Ratio ASTH : 53.96 TER : 85.22
PS Ratio ASTH : 0.38 TER : 14.80
PB Ratio ASTH : 1.56 TER : 16.72
Total Revenue (TTM) ASTH : $3.18B TER : $3.19B
Gross Profit (TTM) ASTH : $230.90M TER : $1.86B
EBITDA (TTM) ASTH : $99.68M TER : $779.72M

Returns By Period

In the year-to-date period, ASTH achieves a -1.17% return, which is significantly lower than TER's 53.23% return. Over the past 10 years, ASTH has underperformed TER with an annualized return of 12.58%, while TER has yielded a comparatively higher 30.61% annualized return.

ASTH

• 1D: 0.74%
• 1M: 20.61%
• YTD: -1.17%
• 6M: -13.51%
• 1Y: -20.93%
• 3Y*: -12.40%
• 5Y*: -2.60%
• 10Y*: 12.58%

TER

• 1D: 7.28%
• 1M: -7.36%
• YTD: 53.23%
• 6M: 115.64%
• 1Y: 260.24%
• 3Y*: 40.80%
• 5Y*: 18.61%
• 10Y*: 30.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ASTH vs. TER — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASTH

ASTH Risk / Return Rank: 29
ASTH Sharpe Ratio Rank: 28
ASTH Sortino Ratio Rank: 31
ASTH Omega Ratio Rank: 31
ASTH Calmar Ratio Rank: 27
ASTH Martin Ratio Rank: 28

TER

TER Risk / Return Rank: 98
TER Sharpe Ratio Rank: 99
TER Sortino Ratio Rank: 98
TER Omega Ratio Rank: 96
TER Calmar Ratio Rank: 99
TER Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASTH vs. TER - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Astrana Health Inc (ASTH) and Teradyne, Inc. (TER). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ASTH	TER	Difference
Sharpe ratio Return per unit of total volatility	-0.28	4.21	-4.49
Sortino ratio Return per unit of downside risk	0.07	4.28	-4.21
Omega ratio Gain probability vs. loss probability	1.01	1.57	-0.56
Calmar ratio Return relative to maximum drawdown	-0.42	12.75	-13.17
Martin ratio Return relative to average drawdown	-0.79	38.79	-39.58
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ASTH vs. TER - Sharpe Ratio Comparison

The current ASTH Sharpe Ratio is -0.28, which is lower than the TER Sharpe Ratio of 4.21. The chart below compares the historical Sharpe Ratios of ASTH and TER, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ASTH	TER	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.28	4.21	-4.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.04	0.39	-0.43
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	0.70	-0.57
Sharpe Ratio (All Time) Calculated using the full available price history	0.13	0.21	-0.08

Correlation

The correlation between ASTH and TER is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ASTH vs. TER - Dividend Comparison

ASTH has not paid dividends to shareholders, while TER's dividend yield for the trailing twelve months is around 0.17%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ASTH Astrana Health Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TER Teradyne, Inc.	0.17%	0.25%	0.38%	0.41%	0.50%	0.24%	0.33%	0.53%	1.15%	0.67%	0.94%	1.16%

Drawdowns

ASTH vs. TER - Drawdown Comparison

The maximum ASTH drawdown since its inception was -84.80%, smaller than the maximum TER drawdown of -97.30%. Use the drawdown chart below to compare losses from any high point for ASTH and TER.

Drawdown Indicators

	ASTH	TER	Difference
Max Drawdown Largest peak-to-trough decline	-84.80%	-97.30%	+12.50%
Max Drawdown (1Y) Largest decline over 1 year	-46.67%	-20.35%	-26.32%
Max Drawdown (5Y) Largest decline over 5 years	-84.80%	-59.12%	-25.68%
Max Drawdown (10Y) Largest decline over 10 years	-84.80%	-59.12%	-25.68%
Current Drawdown Current decline from peak	-79.47%	-13.52%	-65.95%
Average Drawdown Average peak-to-trough decline	-46.80%	-58.93%	+12.13%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.07%	6.69%	+18.38%

Volatility

ASTH vs. TER - Volatility Comparison

The current volatility for Astrana Health Inc (ASTH) is 12.93%, while Teradyne, Inc. (TER) has a volatility of 23.19%. This indicates that ASTH experiences smaller price fluctuations and is considered to be less risky than TER based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ASTH	TER	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.93%	23.19%	-10.26%
Volatility (6M) Calculated over the trailing 6-month period	58.76%	45.67%	+13.09%
Volatility (1Y) Calculated over the trailing 1-year period	73.90%	62.25%	+11.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	65.53%	47.65%	+17.88%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	93.76%	43.72%	+50.04%

Financials

ASTH vs. TER - Profitability Comparison

The chart below illustrates the profitability comparison between Astrana Health Inc and Teradyne, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ASTH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Astrana Health Inc reported a gross profit of 0.00 and revenue of 950.53M. Therefore, the gross margin over that period was 0.0%.

TER - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Teradyne, Inc. reported a gross profit of 622.85M and revenue of 1.08B. Therefore, the gross margin over that period was 57.5%.

ASTH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Astrana Health Inc reported an operating income of 18.40M and revenue of 950.53M, resulting in an operating margin of 1.9%.

TER - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Teradyne, Inc. reported an operating income of 310.18M and revenue of 1.08B, resulting in an operating margin of 28.6%.

ASTH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Astrana Health Inc reported a net income of 6.00M and revenue of 950.53M, resulting in a net margin of 0.6%.

TER - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Teradyne, Inc. reported a net income of 257.22M and revenue of 1.08B, resulting in a net margin of 23.7%.